SEC Filing Details
Document Details
Form
Filing Date
Mar 25, 2016
Document Date
Mar 22, 2016
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Eiger BioPharmaceuticals
Issuer
EIGER BIOPHARMACEUTICALS, INC.
Filer
ENGLEMAN EDGAR